Related Experiment Video
Updated: Aug 8, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell
Brent E Palmer1, Naomi Blyveis, Andrew P Fontenot
1Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Insights
In HIV-1 infection, CD57+CD4+ T cells are proliferation-incompetent and increase with chronic antigen exposure. This CD57 expression persists even with effective antiretroviral therapy, offering insights into HIV immunopathogenesis.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- HIV-1 infection impairs CD4+ T cell proliferation and skews them towards an IFN-gamma-producing, CCR7- phenotype.
- CD57 expression on CD8+ T cells is linked to senescence, but its role in CD4+ T cells during HIV-1 is less understood.
Purpose of the Study:
- To investigate the frequency, phenotype, and function of CD57-expressing CD4+ T cells in HIV-1-infected individuals.
- To determine if CD57+CD4+ T cells are proliferation-incompetent and how their expression is affected by HIV-1 infection and treatment.
Main Methods:
- Flow cytometry was used to analyze CD57 expression on CD4+ T cells.
- Proliferation assays were performed using mitogen stimulation.
- Analysis included HIV-1-infected subjects (n=25) and seronegative controls (n=10).
Main Results:
- CD57+CD4+ T cells were found to be proliferation-incompetent, even with strong stimulation.
- Higher percentages of CD57+CD4+ T cells were observed in untreated HIV-1 subjects compared to controls.
- CD57 expression on CD4+ T cells did not normalize with effective antiretroviral therapy and was predominantly on CCR7- cells, particularly those producing only IFN-gamma.
Conclusions:
- A novel population of proliferation-incompetent CD4+ T cells expressing CD57 is generated during chronic antigen exposure in HIV-1 infection.
- These CD57+CD4+ T cells are a persistent feature, even with treatment, contributing to understanding HIV immunopathogenesis.
Abstract:
HIV-1 replication is associated with reduced or absent HIV-1-specific CD4+ T cell proliferation and skewing of HIV-1-specific CD4+ T cells toward an IFN-gamma-producing, CCR7- phenotype. The CCR7- T cell population is heterogeneous and can be subdivided based on the expression of CD57. Although CD57 expression on CD8+ T cells is associated with proliferation incompetence and replicative senescence, less is known about the function of CD57-expressing CD4+ T cells. In this study, the frequency, phenotype, and function of CD57+CD4+ T cells were evaluated in 25 HIV-1-infected subjects and 10 seronegative controls. CD57+CD4+ T cells were found to be proliferation incompetent, even after strong mitogen stimulation. Percentages of CD4+ T cells that expressed CD57 were significantly higher in untreated HIV-1-infected subjects than in HIV-1-seronegative donors, and CD57 expression did not normalize in subjects receiving at least 6 mo of effective antiretroviral therapy. CD57 was predominately expressed on the CCR7- fraction of the CD4+ T cell compartment and accounted for the majority of cells in the CCR7-CD45RA+ population from untreated HIV-1-infected subjects. HIV-1-specific CD4+ T cells producing only IFN-gamma had the highest expression of CD57, whereas few cells producing IL-2 alone expressed CD57. These findings further define a novel population of proliferation-incompetent CD4+ T cells that are generated in the presence of chronic Ag exposure. A better understanding of the generation and persistence of CD57+ T cells in HIV-1 infection could provide important insights into the immunopathogenesis of this disease.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

